• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Arab Journal of Nuclear Sciences and Applications
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 54 (2021)
Issue Issue 2
Issue Issue 1
Volume Volume 53 (2020)
Volume Volume 52 (2019)
Volume Volume 51 (2018)
El-Sabagh, H., amin, A., Mourad, M., Abo-Elenein, S. (2021). Radioiodination of Quetiapine and Cyclobenzaprine as Brain Monitoring Agents: Comparative Study on SPECT Imaging. Arab Journal of Nuclear Sciences and Applications, 54(2), 9-18. doi: 10.21608/ajnsa.2021.32138.1364
Hanan El-Sabagh; abeer Mohamed amin; Mai Adel Mourad; Salah Abo-Elenein. "Radioiodination of Quetiapine and Cyclobenzaprine as Brain Monitoring Agents: Comparative Study on SPECT Imaging". Arab Journal of Nuclear Sciences and Applications, 54, 2, 2021, 9-18. doi: 10.21608/ajnsa.2021.32138.1364
El-Sabagh, H., amin, A., Mourad, M., Abo-Elenein, S. (2021). 'Radioiodination of Quetiapine and Cyclobenzaprine as Brain Monitoring Agents: Comparative Study on SPECT Imaging', Arab Journal of Nuclear Sciences and Applications, 54(2), pp. 9-18. doi: 10.21608/ajnsa.2021.32138.1364
El-Sabagh, H., amin, A., Mourad, M., Abo-Elenein, S. Radioiodination of Quetiapine and Cyclobenzaprine as Brain Monitoring Agents: Comparative Study on SPECT Imaging. Arab Journal of Nuclear Sciences and Applications, 2021; 54(2): 9-18. doi: 10.21608/ajnsa.2021.32138.1364

Radioiodination of Quetiapine and Cyclobenzaprine as Brain Monitoring Agents: Comparative Study on SPECT Imaging

Article 2, Volume 54, Issue 2, Spring 2021, Page 9-18  XML PDF (1.22 MB)
Document Type: Original Article
DOI: 10.21608/ajnsa.2021.32138.1364
Authors
Hanan El-Sabagh email 1; abeer Mohamed amin2; Mai Adel Mourad3; Salah Abo-Elenein4
1Labeled compounds,Hot Labs center,EAEA,Cairo,Egypt
2Labeled compounds,Hot labs center, EAEA
3Centre of Radiation Oncology and Nuclear Medicine, Kasr Al-Ainy, Cairo, Egypt
4Chemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
Abstract
The aim of this study is to use new drugs capable of crossing the blood-brain barrier (BBB) to develop new radiopharmaceuticals for non-invasive brain imaging. Quetiapine (QTP) and cyclobenzaprine (CBP), as two 5-HT2A receptor antagonists, were successfully labeled with radioactive iodine (125I) using Chloramine-T (CAT) as an oxidizing agent via electrophilic substitution reactions. After studying the parameters affecting the labeling yield (substrate amount, CAT amount, pH of the reaction mix., reaction time and temperature), the highest radiochemical yields of125I-QTP and 125I-CBP were found to be 94.5 % ± 1.0 and 91.7 % ± 0.6, respectively, at pH 2. The biodistribution and the SPECT/CT image showed that the maximum uptake of radioiodinated-QTP by the mouse brain was 10.2% and 10.9% at 120 minutes post-injection, while the radioiodinated-CBP was 7.7% and 12.4% at 240 minutes post-injection. The results have shown that radioiodinated-QTP and radioiodinated-CBP are novel radiopharmaceuticals and may be used for brain imaging.
Keywords
Radioiodination; Quetiapine; Cyclobenzaprine; Biodistribution; Brain imaging; SPECT/CT
Statistics
Article View: 206
PDF Download: 51
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.